WEST PALM BEACH, Fla. — A review of studies on MS prognosis revealed that sex differences and hormones are correlated with age, according to a presentation at the ACTRIMS Forum.
“The aim (of research and developing clinical solutions) is to prevent or delay the transition from asymptomatic RIS to symptomatic MS, to also improve recovery and (create) a slower transition to the progressive phase of MS as well as symptom worsening,” Burcu Zeydan, MD, PhD, assistant professor of neurology and radiology at the Mayo Clinic, said during the presentation.
Citing more than two dozen